Background: Sanger sequencing of plasma RNA is the standard method for HIV-1 drug resistance testing in treatment-naive patients, but is limited by the non-detection of resistance-associated mutations (RAMs) with prevalence below approximately 20%. Objectives: We compared RNA and DNA Sanger sequencing (RSS and DSS) with RNA next-generation sequencing (NGS) for RAM detection in HIV-1 reverse transcriptase (RT), protease (PR) and integrase (IN) genes. Methods: Sanger sequencing was performed on RNA and DNA, following the recommendations of the French Agency for AIDS Research (ANRS). NGS was performed on RNA using the HIV-1 Drug Resistance Assay, v. 3.0 (Roche) on the 454 GS Junior sequencer. The IAS-USA list was used to identify RAMs. ANRS, Rega and Stanford algorithms were used for drug resistance interpretation. Results: The study included 48 ART-naive patients. The number of patients with at least one major RAM was 3, 3, 4 and 8 when using RSS, DSS, NGS 20% and NGS 5%, respectively. Numerous minor mutations were detected in patients, especially in the protease gene. None of the methods detected any major mutation in the integrase gene. Overall, the mutation detection rate was similar between RSS and DSS, and higher with NGS 20%. Differences in drug resistance interpretation were found between algorithms. No impact of the minority RAMs detected by NGS was found on the short-term treatment outcome. Conclusions: DSS does not clearly improve the detection of RAMs in ART-naive patients, as compared with RSS. NGS allows detection of additional minority RAMs; however, their clinical relevance requires further investigation.
Background: Sanger sequencing of plasma RNA is the standard method for HIV-1 drug resistance testing in treatment-naive patients, but is limited by the non-detection of resistance-associated mutations (RAMs) with prevalence below approximately 20%. Objectives: We compared RNA and DNA Sanger sequencing (RSS and DSS) with RNA next-generation sequencing (NGS) for RAM detection in HIV-1 reverse transcriptase (RT), protease (PR) and integrase (IN) genes. Methods: Sanger sequencing was performed on RNA and DNA, following the recommendations of the French Agency for AIDS Research (ANRS). NGS was performed on RNA using the HIV-1 Drug Resistance Assay, v. 3.0 (Roche) on the 454 GS Junior sequencer. The IAS-USA list was used to identify RAMs. ANRS, Rega and Stanford algorithms were used for drug resistance interpretation. Results: The study included 48 ART-naive patients. The number of patients with at least one major RAM was 3, 3, 4 and 8 when using RSS, DSS, NGS 20% and NGS 5%, respectively. Numerous minor mutations were detected in patients, especially in the protease gene. None of the methods detected any major mutation in the integrase gene. Overall, the mutation detection rate was similar between RSS and DSS, and higher with NGS 20%. Differences in drug resistance interpretation were found between algorithms. No impact of the minority RAMs detected by NGS was found on the short-term treatment outcome. Conclusions: DSS does not clearly improve the detection of RAMs in ART-naive patients, as compared with RSS. NGS allows detection of additional minority RAMs; however, their clinical relevance requires further investigation.
Authors: Kazeem Adeboyejo; Victória Riquena Grosche; Diego Pandeló José; Giulia Magalhães Ferreira; Jacqueline Farinha Shimizu; Barnabas J King; Alexander W Tarr; Márcia Maria Costa Nunes Soares; Jonathan K Ball; C Patrick McClure; Ana Carolina Gomes Jardim Journal: Access Microbiol Date: 2022-03-02
Authors: Xi Yang; Marjan M Hashemi; Nadya Andini; Michelle M Li; Shuzhen Kuang; Karen C Carroll; Tza-Huei Wang; Samuel Yang Journal: J Antimicrob Chemother Date: 2020-07-01 Impact factor: 5.790
Authors: Andrea Arias; Pablo López; Raphael Sánchez; Yasuhiro Yamamura; Vanessa Rivera-Amill Journal: Int J Environ Res Public Health Date: 2018-08-09 Impact factor: 3.390
Authors: Kamwing Jair; Chase D McCann; Harrison Reed; Amanda D Castel; Marcos Pérez-Losada; Brittany Wilbourn; Alan E Greenberg; Jeanne A Jordan Journal: PLoS One Date: 2019-04-09 Impact factor: 3.240
Authors: Keylie M Gibson; Kamwing Jair; Amanda D Castel; Matthew L Bendall; Brittany Wilbourn; Jeanne A Jordan; Keith A Crandall; Marcos Pérez-Losada Journal: Sci Rep Date: 2020-02-06 Impact factor: 4.379
Authors: Emma R Lee; Neil Parkin; Cheryl Jennings; Chanson J Brumme; Eric Enns; Maria Casadellà; Mark Howison; Mia Coetzer; Santiago Avila-Rios; Rupert Capina; Eric Marinier; Gary Van Domselaar; Marc Noguera-Julian; Don Kirkby; Jeff Knaggs; Richard Harrigan; Miguel Quiñones-Mateu; Roger Paredes; Rami Kantor; Paul Sandstrom; Hezhao Ji Journal: Sci Rep Date: 2020-01-31 Impact factor: 4.379
Authors: Santiago Ávila-Ríos; Neil Parkin; Ronald Swanstrom; Roger Paredes; Robert Shafer; Hezhao Ji; Rami Kantor Journal: Viruses Date: 2020-06-05 Impact factor: 5.048